Clinical Trial Update: Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating chemoradiotherapy for esophageal cancer or esophagogastric junction cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophagogastric Junction Cancer

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Esophagus Cancer, Esophagogastric Junction Cancer | Phase 3 | Status: RECRUITING